Journal of Cancer Research and Therapeutics

CASE REPORT
Year
: 2009  |  Volume : 5  |  Issue : 2  |  Page : 130--132

Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab


Alaattin Ozen1, Irfan Cicin2, Atakan Sezer3, Sernaz Uzunoglu2, Mert Saynak1, Hakan Genchellac4, Hakan Karagol2 
1 Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey
2 Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey
3 Department of General Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey
4 Department of Radiology, Faculty of Medicine, Trakya University, Edirne, Turkey

Correspondence Address:
Irfan Cicin
Medikal Onkoloji Bilim Dal?,Trakya Universitesi Hastanesi, Edirne - 22030
Turkey

The adverse effects of regimes in cancer treatment have forced us to change to new targeted therapy options. Understanding these side effects, which can lead to discontinuation of the new therapy strategies, will allow the clinical management of these side effects and result in continuing therapies with effective medications. Bevacizumab, which is an IgG1 antibody against vascular endothelial growth factor, has side effects such as proteinuria, hypertension, venous and arterial thromboembolic events, and hemorrhage. This is the first reported case of dural sinus vein thrombosis, during the treatment with bevacizumab.


How to cite this article:
Ozen A, Cicin I, Sezer A, Uzunoglu S, Saynak M, Genchellac H, Karagol H. Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab.J Can Res Ther 2009;5:130-132


How to cite this URL:
Ozen A, Cicin I, Sezer A, Uzunoglu S, Saynak M, Genchellac H, Karagol H. Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab. J Can Res Ther [serial online] 2009 [cited 2021 Apr 13 ];5:130-132
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2009;volume=5;issue=2;spage=130;epage=132;aulast=Ozen;type=0